HeimSBHMY • OTCMKTS
add
Sino Biopharmaceutical Unsponsored Caymand Islands ADR
Við síðustu lokun
9,65 $
Dagbil
9,55 $ - 9,55 $
Árabil
6,69 $ - 9,65 $
Markaðsvirði
68,96 ma. HKD
Meðalmagn
42,00
Í fréttum
Fjármál
Rekstrarreikningur
Tekjur
Nettótekjur
(CNY) | jún. 2024info | Breyting á/á |
---|---|---|
Tekjur | 7,94 ma. | 11,14% |
Rekstrarkostnaður | 4,78 ma. | 10,58% |
Nettótekjur | 1,51 ma. | 139,69% |
Hagnaðarhlutfall | 19,01 | 115,78% |
Hagnaður á hvern hlut | — | — |
EBITDA | 1,98 ma. | 8,88% |
Virkt skatthlutfall | 16,99% | — |
Efnahagsreikningur
Heildareignir
Heildarskuldir
(CNY) | jún. 2024info | Breyting á/á |
---|---|---|
Reiðufé og skammtímafjárfestingar | 13,18 ma. | -15,93% |
Heildareignir | 66,70 ma. | 1,62% |
Heildarskuldir | 24,58 ma. | -15,76% |
Eigið fé alls | 42,12 ma. | — |
Útistandandi hlutabréf | 18,21 ma. | — |
Eiginfjárgengi | 5,36 | — |
Arðsemi eigna | 6,50% | — |
Ávöxtun eigin fjár | 8,37% | — |
Peningaflæði
Breyting á handbæru fé
(CNY) | jún. 2024info | Breyting á/á |
---|---|---|
Nettótekjur | 1,51 ma. | 139,69% |
Handbært fé frá rekstri | 1,54 ma. | 15,25% |
Reiðufé frá fjárfestingum | -1,02 ma. | 49,91% |
Reiðufé frá fjármögnun | -2,05 ma. | -1,42% |
Breyting á handbæru fé | -1,52 ma. | 43,37% |
Frjálst peningaflæði | 1,09 ma. | 36,59% |
Um
Sino Biopharmaceutical Limited, shortly Sino Biopharm, is a civilian-run enterprise principally engaged in the medicine products business in Mainland China.
Being a member of Charoen Pokphand Group and headquartered in Hong Kong and Beijing, Sino Biopharm is engaged in researching, developing, producing, and selling biopharmaceutical products for the medical treatment of ophthalmia, as well as modernized Chinese medicine and chemical medicine for the treatment of hepatitis through its subsidiaries.
Sino Biopharm is also involved in other minor businesses through its subsidiaries, such as properties, health food, optical glass, optical and auditory products. Wikipedia
Framkvæmdastjóri
Stofnsett
2000
Vefsvæði
Starfsfólk
24.437